Future Pill for Premature Ejaculation

A new tablet could hold the key for men who suffer premature ejaculation, reports Marina Murphy in Chemistry & Industry Magazine. Trials by a US company have shown the pill, compound LI 301, to have an effect on everyone tested. Trials suggest the drug starts working within two hours, so it could be taken on an as-needed basis.

Currently, there are no approved treatments for premature ejaculation. There is no definite date set for the release of LI 301 although some estimates suggest it could be available as soon as 2007. Other compounds being investigated for premature ejaculation are producing mixed results, but the new pill works in a different and unique way. It is thought that its success in trials is due to an analgesic effect that causes a dulling of sensation and a reduction in feeling. But, at the right dose, this does not affect orgasm and normal sexual function is retained.

‘People do not like the interference factor of creams and devices and are moving toward being able to take a pill,’ says Chris Every, CEO of Enhance Biotech, New York, the company developing the drug.

‘Anything that improves the sex lives of men and women has to be a good thing,’ says Jim Pollard, editor of Male Health, ‘But,’ he says, ‘this has to be balanced with the over-medication of the area. The secret to good sex is really communication between the two people involved.’

Media Contact

Lizzy Ray alfa

Weitere Informationen:

http://www.chemind.org

Alle Nachrichten aus der Kategorie: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

Cyanobacteria: Small Candidates …

… as Great Hopes for Medicine and Biotechnology In the coming years, scientists at the Chair of Technical Biochemistry at TU Dresden will work on the genomic investigation of previously…

Do the twist: Making two-dimensional quantum materials using curved surfaces

Scientists at the University of Wisconsin-Madison have discovered a way to control the growth of twisting, microscopic spirals of materials just one atom thick. The continuously twisting stacks of two-dimensional…

Big-hearted corvids

Social life as a driving factor of birds’ generosity. Ravens, crows, magpies and their relatives are known for their exceptional intelligence, which allows them to solve complex problems, use tools…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close